Technology

FEAR IS BIGGER THAN EVER… AND ZERO LATENCY VR HAS THE SCIENCE TO PROVE IT

Published

38 minutes ago

October 1, 2026

Ahead of Halloween, Zero Latency VR brought in “scientist of fear” Dr. Coltan Scrivner to explain why people can’t stop playing with the things that scare them

MELBOURNE, Australia, Oct. 1, 2026 /PRNewswire/ — Zero Latency VR, the world’s largest and most innovative immersive VR network, is celebrating a double Halloween anniversary: three years since the launch of Outbreak, its free-roam zombie survival shooter, and one year since the debut of Haunted, its immersive haunted house experience. Rather than mark the occasion alone, the company brought in an outside expert: Dr. Coltan Scrivner, a research scientist who studies why humans seek out frightening things for fun.

In three years, Outbreak has thrown wave after wave of the undead at guests across Zero Latency’s venues worldwide. In the year since, Haunted has barely let anyone make it through the lobby without a scream. Between the two, Halloween has become the company’s busiest and loudest season, leading Zero Latency to ask Scrivner a simple question: why do we pay money to be scared on purpose?

Scrivner is a research scientist at Arizona State University known for his work on morbid curiosity, horror, and what he calls “recreational fear”; the mixed feeling of fear and enjoyment that draws people to haunted houses, horror films, and survival games. He is the author of Morbidly Curious: A Scientist Explains Why We Can’t Look Away, and his research has been featured in The New York Times, CNN, The Economist, NPR and Scientific American.

“Humans are built to play with the things that frighten us,” said Scrivner. “It’s a great way for us to learn how to better regulate our fear and anxiety. One of the best ways to learn how you and your friends react in stressful situations is to simulate a stressful situation, and immersive VR is unmatched in its ability to safely invoke fear while maintaining a playful psychological frame.”

According to Scrivner, that’s exactly what sets free-roam VR apart from other horror formats. “The very best scary games blur the line between fiction and reality,” he said. “Immersive VR pushes that boundary and opens up a whole new way to play with fear. I have never experienced a horror game as immersive as Haunted or Outbreak, both of them were scarier, and more fun, than I could have imagined.”

“We’ve had over eleven years to perfect the jump scare, and it turns out you can’t fake it. The science backs it up,” said Tim Ruse, CEO of Zero Latency VR. “If you’re not leaving Outbreak with a slightly elevated heart rate, or leaving Haunted a little rattled, we haven’t done our job. It’s nice to finally have someone with a PhD confirm that’s a good thing.”

Zero Latency has two special Halloween double-features this spooky season; guests can experience Haunted and Undead Arena, the post-apocalyptic zombie shooter game show, or combine Outbreak with Outbreak 2: Mall Mayhem for a full hour of adrenaline-filled zombie survival that will truly get the blood pumping. Book now.

ABOUT ZERO LATENCY VR:

Zero Latency VR is the global pioneer in immersive entertainment, pushing the boundaries of what’s possible in location-based experiences. As the largest free-roam VR network on the planet, with 150+ cutting-edge venues across 34 countries, Zero Latency is where thrill-seekers come to live out their wildest fantasies.

SOCIAL MEDIA LINKS:

Instagram and TikTok: @zerolatencyvr

LinkedIn: Zero Latency VR

Press Contact:

Luke Mitchell

PR & Communications Manager

+61 (0) 413614412

luke.mitchell@zerolatencyvr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/fear-is-bigger-than-ever-and-zero-latency-vr-has-the-science-to-prove-it-302895855.html

SOURCE Zero Latency VR

Technology

BOSGAME Brings Everyday Computing Upgrades to Amazon Prime Big Deal Days 2026

Published

38 minutes ago

October 1, 2026

Selected Mini PCs will be available at 20% to 35% off for a limited time on October 6–7

NEW YORK, Oct. 1, 2026 /PRNewswire/ — BOSGAME, a technology-based electronic product brand, will participate in Amazon Prime Big Deal Days 2026, offering limited-time savings on selected Mini PCs from October 6-7. Starting at 12:00 a.m. PDT on October 6, shoppers can save 20‑35% on list prices on featured models, offering a timely opportunity to upgrade their everyday computing setup for less.

As computers take on more tasks at home, consumers may prioritize different needs depending on how and where they use their devices. From home-office productivity and online learning to web browsing and media consumption, a compact PC can provide a practical computing option while taking up minimal desk space.

During Prime Big Deal Days, BOSGAME will feature four Mini PCs with different configurations to suit a range of everyday needs and budgets.

BOSGAME E5: Powered by AMD Ryzen 5 5300U, the E5 handles everyday office work, web browsing and multitasking. Triple-display support and a compact, VESA-mountable design help maximize workspace in home offices or smaller desk setups.BOSGAME E5 Plus: Built for flexible home and office productivity, the E5 Plus combines AMD Ryzen 5 5400U performance with triple 4K display support. Upgradeable memory and expandable storage also leave room for evolving computing needs.BOSGAME E2 Plus: Designed for work, study and home use, the E2 Plus supports document editing, online meetings, learning and streaming. Its compact design and triple-display capability suit classrooms, home offices and other everyday spaces.BOSGAME E3 Neo: Powered by Intel N95, the E3 Neo offers a compact solution for essential home and office computing. Triple 4K display support and 2.5G LAN add flexibility for multi-screen setups and reliable wired connectivity.

The promotion runs through October 7, with savings of up to 35%, subject to product availability and Amazon’s promotional terms.

Whether upgrading a home-office setup, adding a computer for study, or choosing a compact device for browsing and entertainment, shoppers can explore BOSGAME’s featured Mini PCs during Amazon Prime Big Deal Days. For full promotion and product details, please visit the BOSGAME Amazon storefront at https://www.amazon.com/stores/BOSGAME/page/66639804-4D20-4901-A26F-0E6FE3715282.

View original content to download multimedia:https://www.prnewswire.com/news-releases/bosgame-brings-everyday-computing-upgrades-to-amazon-prime-big-deal-days-2026-302890863.html

SOURCE Bosgame

Technology

Fulton Financial Corporation Announces Dates for Third Quarter 2026 Earnings Release and Webcast

Published

38 minutes ago

October 1, 2026

LANCASTER, Pa., Oct. 1, 2026 /PRNewswire/ — Fulton Financial Corporation (“Fulton”) (Nasdaq: FULT) today announced that it will distribute its third quarter 2026 earnings release and accompanying charts on Wednesday, October 21, at approximately 4:30 p.m. Eastern Time.

Fulton will host a conference call with analysts on Thursday, October 22, at 10 a.m. Eastern Time. Curt Myers, Chairman, CEO and President, will host the call. He will be joined by Rick Kraemer, Senior Executive Vice President and CFO.

The link to the webcast of this call can be found at https://investor.fultonbank.com. Participants can also access the audio-only webcast at: https://edge.media-server.com/mmc/p/yj9w42yd.

Fulton, a more than $34 billion Lancaster, Pa.-based financial holding company, has more than 3,400 employees and operates more than 200 financial centers in Pennsylvania, New Jersey, Maryland, Delaware and Virginia through Fulton Bank, N.A.

Additional information on Fulton can be found at https://investor.fultonbank.com.

Media Contact: Rachel Sharkey (717) 291-2831
Investor Contact: Patrick Lafferty (717) 327-2556

View original content to download multimedia:https://www.prnewswire.com/news-releases/fulton-financial-corporation-announces-dates-for-third-quarter-2026-earnings-release-and-webcast-302896285.html

SOURCE Fulton Financial Corporation

Technology

Avimer Bio and CNIO Advance Protein Cage Design for Targeted Medicine

Published

38 minutes ago

October 1, 2026

Avimer Bio and CNIO announce JACS publication detailing computational methods to build self-assembling protein cages with atomic precision for targeted medicine.

SAN DIEGO, Oct. 1, 2026 /PRNewswire/ — Avimer Bio, in collaboration with structural biologists at the Spanish National Cancer Research Centre (CNIO), announced a new publication in the Journal of the American Chemical Society (JACS) describing advances in building self-assembling protein cages with atomic precision. The work addresses a longstanding challenge in designing protein assemblies with predictable shapes.

The Technical Achievement
The research addresses how to build predictable protein architectures when building blocks bend as they assemble. Chief Scientific Officer Todd Yeates introduced geometric methods for creating protein cage nanoparticles decades ago at UCLA. Those earlier methods required precise shapes, making structural flexibility a hurdle for designers.
The team developed computer algorithms that predict how spiral-shaped protein segments, called alpha helices, bend. This allows scientists to use the natural flexibility of protein molecules during design. The approach yielded cubic protein cages with minimal mutations to four trimeric protein blocks, twelve subunits in total, reaching molecular masses over 600 kilodaltons while maintaining stability in solution.

“Protein cages require many subunits to fit together in precise arrangements. We used mathematics and mechanical design to identify architectures where the proteins’ natural flexibility helps them adopt the shapes needed for assembly. Combining those principles with modern AI methods gave us a way to design around that flexibility and opens new possibilities for building therapeutic protein assemblies.”
— Todd Yeates, Ph.D., Chief Scientific Officer and Co-Founder, Avimer Bio

Structural Validation
High-resolution cryo-electron microscopy performed at CNIO in Madrid, led by Pablo San Segundo-Acosta and Roger Castells-Graells, confirmed that the physical protein cages matched computational models. Cryo-EM structures reached resolutions of 3.0 to 3.9 angstroms. Differences between the models and measured structures stayed as low as 2 angstroms across the protein backbone. The results confirmed the predicted patterns of helix bending.

Clinical Applications and Advantages
Designed protein cages present multiple copies of therapeutic proteins in controlled arrangements to engage cell receptors. Certain receptors must gather in groups to activate a signaling pathway. A programmable cage controls that grouping beyond the two binding arms on a conventional antibody. Future designs can display different targeting proteins together to direct activity toward selected cell populations.
Potential applications include autoimmune conditions like rheumatoid arthritis and ulcerative colitis, where engaging selected immune cells helps control inflammation. In oncology, therapeutic proteins on a cage can gather receptors that stimulate immune cells to attack tumors.

The platform centers on two distinct properties:

● Few changes to natural protein sequences: The approach preserves much of the starting protein sequence. Applied to human building blocks, it supports designs that retain high similarity to human proteins, providing a rationale for evaluating immune response.● Single protein subunit composition: Each cage builds from a single type of protein subunit. That simplifies production and maintains consistent composition compared to particles requiring several distinct chains.Research Team and Methodology
Robin Aglietti and Peter Bowers conducted the design work at Avimer Bio alongside Todd Yeates. Roger Castells-Graells directed the structural biology team at CNIO during the cryo-electron microscopy analysis.

Publication Details
The complete study, “Design and Structure of Protein Cages Based on Helical Fusion and Machine Learning,” is available in the Journal of the American Chemical Society at https://doi.org/10.1021/jacs.6c11491

About Avimer Bio
Avimer Bio designs programmable protein architectures for targeted therapeutics. Based in San Diego, the company develops computational methods to build protein assemblies that control how therapeutic molecules engage cells and their receptors. For more information, visit www.avimerbio.com

Media Contact:

Adam Sragovicz
adam@avimerbio.com

Press Contact: Adam Sragovicz, https://www.avimerbio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/avimer-bio-and-cnio-advance-protein-cage-design-for-targeted-medicine-302896293.html

SOURCE Avimer Bio